Artificial Intelligence2 years ago
Odyssey Therapeutics Announces Oversubscribed $168 Million Series B Financing
Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced a $168 million Series B financing. This funding, which follows Odyssey’s $218...